Description
Bremelanotide, also referenced as PT-141, is a synthetic cyclic heptapeptide derived from the alpha-melanocyte-stimulating hormone framework. It behaves as a non-selective melanocortin receptor agonist in experimental systems.
Research applications have included melanocortin receptor signal transduction, centrally mediated behavioral responses, and second-messenger cascade analysis within rodent and cultured-cell models. Its defined receptor engagement supports mechanistic study of the melanocortin system.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.